A Phase 2 interventional study of Dexamethasone Dose 1 and Dexamethasone Dose 2 in Cataract in Inflammatory Ocular Disorders, sponsored by iDrop, Inc.. Completed at 1 site in El Salvador. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2021-01-15.
Sponsored by iDrop, Inc. · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Patients at least 40 years of age who are undergoing cataract surgery will be randomized to receive treatment with one of four groups of dexamethasone ophthalmic suspension or placebo eye drops to determine if the drops decrease inflammation and pain inside the eye and are safe after cataract surgery.
"Patients undergoing traditional cataract surgery routinely develop inflammation and pain. This study will evaluate 4 arms of either dexamethasone or placebo.
1,632 studies on the registry are indexed under Cataract; 235 are open to participants now.
This study's enrollment of 60 is below the median of 79 across 1,094 interventional studies indexed under Cataract.
Browse Cataract studies →iDrop, Inc. is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Drug: Dexamethasone Dose 1
Drug: Dexamethasone Dose 2
Drug: Placebo Dose 1
Drug: Placebo Dose 2
Dexamethasone ophthalmic suspension dose 1
Dexamethasone ophthalmic suspension dose 2
Placebo suspension dose 1
Placebo suspension dose 2
Ocular inflammation
Measuring Anterior Cell Count
Time frame: Day 8
Ocular Pain
Measuring patient ocular pain using an 11-point visual scale
Time frame: Day 8
Plan to share: No
No publications or documents are linked to this record.
Ran from Sep 2020 to primary completion in Oct 2020, 1 month.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
iDrop, Inc.